SCHEMBL14337992

SCHEMBL14337992

CCOc1cc(P(=O)(c2ccc(C)cc2)c2ccc(C)cc2)c(I)c2c1OCO2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.36
AOC3 Q16853 1/20 0.35
ALDH1A1 P00352 4/20 0.33
LMNA P02545 4/20 0.33
KDM4E B2RXH2 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAPT P10636 6/20 0.32
POLB P06746 4/20 0.32
MEN1 O00255 5/20 0.31
KMT2A Q03164 5/20 0.31
TSHR P16473 2/20 0.31
USP2 O75604 1/20 0.31
DHFR P00374 1/20 0.31
HSD17B10 Q99714 1/20 0.31
RAB9A P51151 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
KCNMA1 Q12791 1/20 0.31
HPGD P15428 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5391917 0.89 KMT2A (0.38) AOC3ALDH1A1LMNAKDM4ESMN1; SMN2
SCHEMBL14337994 0.89 AOC3 (0.33) EGFRAOC3ALDH1A1MAPTDHFR
SCHEMBL5385283 0.86 POLB (0.37) ALDH1A1LMNAKDM4ESMN1; SMN2MAPT
SCHEMBL14350690 0.86 AOC3 (0.36) EGFRAOC3ALDH1A1LMNAKDM4E
SCHEMBL14337937 0.86 EGFR (0.36) EGFRAOC3ALDH1A1LMNAKDM4E
SCHEMBL14337877 0.86 EGFR (0.36) EGFRAOC3ALDH1A1LMNAKDM4E
SCHEMBL14337993 0.83 CYP3A4 (0.33) AOC3POLB
SCHEMBL14338009 0.82 ALDH1A1 (0.32) ALDH1A1LMNAKDM4ESMN1; SMN2L3MBTL1
SCHEMBL14338000 0.81 POLB (0.34) ALDH1A1LMNAKDM4ESMN1; SMN2MAPT
SCHEMBL14337997 0.81 HPGD (0.33) ALDH1A1LMNAKDM4ESMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312347-B2 Substituted optically active disphosphine compound TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-12-25 US disclosed
US-7312347-B2 Substituted optically active disphosphine compound TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-12-25 US disclosed
US-20070073065-A1 Substituted optically active disphosphine compound TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-03-29 US disclosed
US-20070073065-A1 Substituted optically active disphosphine compound TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070073065-A1 Substituted optically active disphosphine compound DHPS, DOHH, DHODH EGFR 4169/4885AOC3 1064/4885ALDH1A1 277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.